Meet Mythreya Dharani, the 18-year-old New Jersey student who built an AI model to predict how individual tumors will respond to the chemotherapy drug cisplatin
Efzimfotase alfa demonstrated improvements in bone health in treatment-naïve pediatric patients with hypophosphatasia achieving median difference of 1.67 vs placebo in RGI-C Score at week 25 in MULBERRY Phase III trial